Imaging of atherosclerosis using magnetic resonance: State of the art and future directions

被引:12
作者
Desai M.Y. [1 ]
Lima J.A.C. [1 ]
机构
[1] Division of Cardiology, Johns Hopkins University, Baltimore, MD 21287
关键词
Atherosclerotic Plaque; Magn Reson Image; Arterioscler Thromb Vasc Biol; Coronary Magnetic Resonance Angiography; Vessel Wall Thickness;
D O I
10.1007/s11883-006-0050-8
中图分类号
学科分类号
摘要
Atherosclerosis is the leading cause of morbidity and mortality in industrialized societies, and its incidence is projected to increase in the future. Because the atherosclerotic process begins in the vessel wall, the focus of cardiovascular imaging is shifting from the arterial lumen to imaging of the vessel wall, with the goal of detecting preclinical atherosclerosis. MRI, because of its high resolution, three-dimensional capabilities, noninvasive nature, and capacity for soft tissue characterization, is emerging as an important modality to assess the atherosclerotic plaque burden in the arterial wall and can monitor atherosclerosis in different arterial beds, including the carotid arteries, aorta, and more recently, the coronary arteries. Furthermore, it has also been successfully utilized to monitor plaque regression following therapeutic interventions. Finally, the emergence of high-resolution MRI and development of sophisticated contrast agents offers tremendous promise fo in vivo molecular imaging of the atherosclerotic plaque. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:131 / 139
页数:8
相关论文
共 85 条
[1]  
Fuster V., Badimon L., Badimon J.J., Et al., The pathogenesis of coronary artery disease and the acute coronary syndromes, N Engl J Med, 326, pp. 242-250, (1992)
[2]  
Ross R., Atherosclerosis - An inflammatory disease, N Engl J Med, 340, pp. 115-126, (1999)
[3]  
Glagov S., Weisenberg E., Zarins C.K., Et al., Compensatory enlargement of human atherosclerotic coronary arteries, N Engl J Med, 316, pp. 1371-1375, (1987)
[4]  
Ambrose J.A., Tannenbaum M.A., Alexopoulos D., Et al., Angiographic progression of coronary artery disease and the development of myocardial infarction, J Am Coll Cardiol, 12, pp. 56-62, (1988)
[5]  
Little W.C., Constantinescu M., Applegate R.J., Et al., Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?, Circulation, 78, 5 PART 1, pp. 1157-1166, (1988)
[6]  
George B.S., Combined coronary and peripheral intervention: The oculo-stenotic-dilatory reflex or good medicine?, Catheter Cardiovasc Interv, 52, (2001)
[7]  
Solberg L.A., Strong J.P., Risk factors and atherosclerotic lesions. A review of autopsy studies, Arteriosclerosis, 3, pp. 187-198, (1983)
[8]  
Murray C.J., Lopez A.D., Mortality by cause for eight regions of the world: Global Burden of Disease Study, Lancet, 349, pp. 1269-1276, (1997)
[9]  
Prentice R.L., Surrogate endpoints in clinical trials: Definition and operational criteria, Stat Med, 8, pp. 431-440, (1989)
[10]  
Wittes J., Lakatos E., Probstfield J., Surrogate endpoints in clinical trials: Cardiovascular diseases, Stat Med, 8, pp. 415-425, (1989)